Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/24 17:29 | 3/18/24 | GH | Health | Health | Medical Laboratories | Kalia Kumud | CA | O | CIO | P | 39 | 17.82 | 0 | 2 | 21 | 13 | D | ||||||||||||||
6/13/23 17:42 | 6/9/23 | GH | Health | Health | Medical Laboratories | Kalia Kumud | CA | O | CIO | P.d | 97 | 32.71 | 0 | 3 | 135 | 5 | D | ||||||||||||||
3/16/23 17:24 | 3/14/23 | GH | Health | Health | Medical Laboratories | Eltoukhy Helmy | CA | DO | Co-CEO | P.m | 2,449 | 26.32 | 0 | 93 | 5 | 2,049 | D | ||||||||||||||
3/15/23 18:11 | 3/13/23 | GH | Health | Health | Medical Laboratories | Talasaz Amirali | CA | DO | Co-CEO | P.m | 2,501 | 25.79 | 0 | 97 | 5 | 1,951 | M | ||||||||||||||
11/23/21 19:07 | 11/19/21 | GH | Health | Health | Medical Laboratories | Eltoukhy Helmy | CA | DO | Co-CEO | P.m | 10,048 | 96.15 | 0 | 105 | 5 | 2,322 | D | ||||||||||||||
11/23/21 19:07 | 11/19/21 | GH | Health | Health | Medical Laboratories | Talasaz Amirali | CA | DO | Co-CEO | P.m | 10,044 | 96.12 | 0 | 105 | 5 | 2,325 | D | ||||||||||||||
3/15/19 13:27 | 3/12/19 | GH | Health | Health | Medical Laboratories | Softbank Vision Fund (Aiv M1) L.P. | DE | T | P.a | 20,000 | 9.83 | 0 | 2,034 | 4 | 53,667 | D | |||||||||||||||
3/14/19 15:19 | 3/12/19 | GH | Health | Health | Medical Laboratories | Softbank Vision Fund (Aiv M1) L.P. | DE | T | P | 20,000 | 9.83 | 0 | 2,034 | 4 | 53,667 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |